Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2022 (1)
  • 2021 (3)
  • 2020 (3)
  • 2018 (1)

Subject

  • Diversion Division (3)
  • Prescription Drugs (3)
  • Drug Trafficking (2)
  • Pharmaceuticals/Pharmacists/Physicians (2)
  • Prevention/Education - DEA websites GSAD, JTT etc (1)
  • Synthetic drugs (1)

Drug Name

  • Methamphetamine (209)
  • Fentanyl (112)
  • Cocaine (105)
  • Heroin (81)
  • Marijuana (Cannabis) (17)
  • Opioids (4)
  • Morphine (2)
  • Synthetic Opioids (2)
  • Ecstasy/MDMA (1)
  • Marijuana Concentrates (1)
  • Oxycodone (8)
  • Amphetamines (1)

Field Division

  • New England (62)
  • Atlanta (49)
  • New York (34)
  • Washington, DC (24)
  • Miami (21)
  • Seattle (15)
  • St. Louis (15)
  • San Francisco (10)
  • Houston (6)
  • New Jersey (6)
  • New Orleans (6)
  • Dallas (5)
  • Sede (5)
  • Rocky Mountain (4)
  • Phoenix (2)
  • Detroit (1)
  • El Paso (1)
  • Omaha (1)
  • San Diego (1)
  • Chicago (8)
Clear All Results
PRESS RELEASE

Suburban Chicago Woman Sentenced to 1 Year for Writing Fraudulent Opioid Prescriptions

Enero 18, 2022
CHICAGO - Robert Bell, Special Agent in Charge for the Drug Enforcement Administration Chicago Division, and U.S. Attorney John R. Lausch, Jr., of the Northern District of Illinois today announced that an administrative assistant at a suburban Chicago medical practice has been sentenced to a year in federal prison for...
Enero 18, 2022
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

Septiembre 27, 2021
CHICAGO – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide surge...
Septiembre 27, 2021
PRESS RELEASE

Two Chicago Area Physicians Indicted on Narcotics and Health Care Fraud

Julio 27, 2021
CHICAGO — Special Agent in Charge Robert J. Bell, Drug Enforcement Administration-Chicago Division and John R. Lausch, Jr., United States Attorney for the Northern District of Illinois announced that two suburban Chicago physicians have been indicted on federal criminal charges for allegedly prescribing opioids to individuals who lacked a legitimate...
Julio 27, 2021
PRESS RELEASE

Federal Judge Sentences “Pill Mill” Co-owner to Prison

Marzo 22, 2021
MILWAUKEE – Robert J. Bell, Special Agent in Charge, Drug Enforcement Administration- Chicago Division and Richard G. Frohling, Acting United States Attorney for the Eastern District of Wisconsin, announced today that on March 18, 2021, Susan Moyer (58) of Milwaukee, the former co-owner and office manager of the “Compassionate Care...
Marzo 22, 2021
PRESS RELEASE

Wisconsin physician agrees to pay penalties to resolve allegations of prescribing opioids illegally and violating False Claims Act

Abril 06, 2020
MILWAUKEE - DEA Assistant Special Agent in Charge Paul E. Maxwell and United States Attorney Matthew D. Krueger announced today that Dr. Mehran Heydarpour of Brookfield, Wisconsin, agreed to pay $175,000 to resolve allegations that he prescribed opioid pain medications in violation of the Controlled Substances Act and that he...
Abril 06, 2020
PRESS RELEASE

Wisconsin Dentist Pleads Guilty to Oxycodone Diversion Charge

Marzo 16, 2020
MADISON, WIS. – Assistant Special Agent in Charge Paul E. Maxwell and Scott C. Blader, United States Attorney for the Western Distri ct of Wisconsin, announced that Christopher Kania, 40, Portage, Wisconsin, pled guilty on Thursday, March 12, in U.S. District Court in Madison to obtaining oxycodone by use of...
Marzo 16, 2020
PRESS RELEASE

Leader of prescription fraud ring sentenced to over three years in federal prison

Enero 30, 2020
INDIANAPOLIS – DEA Indianapolis District Office Assistant Special Agent in Charge J. Michael Gannon and United States Attorney Josh J. Minkler announced today, Brandon Fuller, 27, of Chicago, was sentenced to 40 months in federal prison, by U.S. District Judge James R. Sweeney II, after having pleaded guilty to charges...
Enero 30, 2020
PRESS RELEASE

Lasalle County Doctor Sentenced for Dispensing Prescription Drugs to Addicts for Sex

Octubre 16, 2018
CHICAGO - A LaSalle County physician was sentenced today to 12 years in federal prison for illegally dispensing prescription medications, including opioids, in exchange for cash or sex. Constantino Perales, M.D., illegally prescribed oxycodone and Xanax to a patient, Andrew Strandell, knowing that Strandell would sell the pills on the...
Octubre 16, 2018
Showing 1 - 8 of 8 results

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español